MONISTAT 1 COMBINATION PACK OTC
Generic Name and Formulations:
Miconazole 1200mg (vaginal supp), miconazole nitrate 2% (topical crm).
Indications for MONISTAT 1 COMBINATION PACK:
Insert 1 supp vaginally once at bedtime. Crm: apply twice daily as needed for up to 7 days.
Use of contraceptive diaphragm or condoms within 3 days, or use of tampons, douches, or spermicides within 7 days: not recommended. Confirm diagnosis by KOH smears +/or cultures. If ineffective, reconfirm diagnosis before repeating therapy. Discontinue if irritation occur. 1st trimester of pregnancy. Nursing mothers.
May potentiate warfarin.
Vulvovaginal burning, itching or irritation; edema, cramps, nausea, headache, rash, urticaria.
Combination Pack—1x1200mg supp (w. applicator or prefilled applicator) + 9g topical crm
- Neurotoxicity After CAR T-cell Therapy May Be Associated With Endothelial Activation
- Navigation Programs Most Effective in Increasing Follow-up Colonoscopy
- New Class of Clinical Trial Enhances Research on Cancer Care Delivery
- Nivolumab Provides Better Long-Term Efficacy Compared With Docetaxel in NSCLC
- Prophylactic Prochloperazine Ineffective for Opioid-induced Nausea/Vomiting in Cancer
- Anticancer Properties of The Probiotic Kefir: A Review
- Combining Radiation, Immunotherapy: An Emerging Challenge for Oncology Nursing
- Navigating the Transition From Treatment to Breast Cancer Survivor
- Naldemedine Effective for Opioid-Induced Constipation in Cancer Pain
- Disruptions to Circadian Rhythm Linked to Prostate Cancer Surgery Regret
- A Case of Immunotherapy-Induced Myocarditis Concomitant to MG in Lung Cancer
- Daily Aspirin Reduced Risk of HBV-Related Hepatocellular Carcinoma
- Lanreotide Effectively Controls Diarrhea, Flushing in Neuroendocrine Tumors
- Case Report of a KIT-mutated Melanoma Patient With an Excellent Response to Apatinib and Temozolomide Combination Therapy
- Novel Predictive Model More Effectively Identifies Risk for Lung Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|